Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer-Reference-Cited by-同舟云学术

Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer

Published:2016-05-12 Issue:11 Volume:65 Page:1838-1849
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Mahajan Ujjwal M,Teller Steffen,Sendler Matthias,Palankar Raghavendra,van den Brandt Cindy,Schwaiger Theresa,Kühn Jens-Peter,Ribback Silvia,Glöckl Gunnar,Evert Matthias,Weitschies Werner,Hosten Norbert,Dombrowski Frank,Delcea Mihaela,Weiss Frank-Ulrich,Lerch Markus M,Mayerle Julia

Publisher

BMJ

Subject

Gastroenterology

Reference50 articles.

1. Disputed paternity: the uncertain ancestry of pancreatic ductal neoplasia;Maitra;Cancer Cell,2012

2. The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity;Zhang;J Exp Clin Cancer Res,2009

3. Phosphorylation by Cdk1 induces Plk1-mediated vimentin phosphorylation during mitosis;Yamaguchi;J Cell Biol,2005

4. Polo-like kinase 1 is involved in invasion through extracellular matrix;Rizki;Cancer Res,2007

5. Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer;Gray;Mol Cancer Ther,2004

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the causal association between inflammatory cytokines and pancreatic cancer: a two-sample Mendelian randomized study;2024-06-28

2. Recent progress of iron-based nanomaterials in gene delivery and tumor gene therapy;Journal of Nanobiotechnology;2024-06-02

3. HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer;ACS Applied Materials & Interfaces;2024-05-13

4. Noninvasive strategies of cell-tracking in vivo;TrAC Trends in Analytical Chemistry;2024-03

5. SPIONs: Superparamagnetic iron oxide-based nanoparticles for the delivery of microRNAi-therapeutics in cancer;Biomedical Microdevices;2024-02-07